Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire

被引：68
|
作者：
Burger, Maximilian [1 ]
Mulders, Peter [2 ]
Witjes, Wim [3 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Urol, D-91054 Erlangen, Germany
[2] Radboud Univ Nijmegen, Dept Urol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] EAU Cent Res Off, Arnhem, Netherlands
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2012.01.039
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1070 / 1071
页数：3
相关论文
共 50 条
  • [41] Review of Current Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Houede, Nadine
    Pourquier, Philippe
    Beuzebo, Philippe
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (03) : E20 - E25
  • [42] Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database
    Zaid, Harras B.
    Patel, Sanjay G.
    Stimson, C. J.
    Resnick, Matthew J.
    Cookson, Michael S.
    Barocas, Daniel A.
    Chang, Sam S.
    UROLOGY, 2014, 83 (01) : 75 - 80
  • [43] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17
  • [44] Chemotherapy for Muscle-Invasive Bladder Cancer
    Trenta, Patrizia
    Calabro, Fabio
    Cerbone, Linda
    Sternberg, Cora N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
  • [45] Circulating tumour cells to drive the use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
    Beije, N.
    de Kruijff, I. E.
    de Jong, J. J.
    Klaver, S. O.
    de Vries, P.
    Jacobs, R. A. L.
    Somford, D. M.
    te Slaa, E.
    van der Heijden, A. G.
    Witjes, J. Alfred
    Fossion, L. M. C. L.
    Boeve, E. R.
    van der Hoeven, J.
    van Melick, H. H. E.
    Wijburg, C. J.
    Bickerstaffe, H.
    Martens, J. W. M.
    de Wit, R.
    Kraan, J.
    Sleijfer, S.
    Boormans, J. L.
    ESMO OPEN, 2022, 7 (02)
  • [46] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
    Peyrottes, Arthur
    Ouzaid, Idir
    Califano, Gianluigi
    Hermieu, Jean-Francois
    Xylinas, Evanguelos
    MEDICINA-LITHUANIA, 2021, 57 (08):
  • [47] Neoadjuvant therapy for muscle-invasive bladder cancer
    Jain, Rohit K.
    Sonpavde, Guru
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 603 - 614
  • [48] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
    Elsayed, Dalia Hamouda
    Elfarargy, Ola M.
    Elderey, Mohamed Salah
    Mandour, Doaa
    Atef, Nora
    Hemeda, Rehab
    Kamel, Mostafa
    Azony, Ahmed
    Taha, Heba F.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01): : 1 - 9
  • [49] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?
    Catarino, Raquel
    Alves, Luisa
    Pereira, Diogo
    Costa, Gabriel
    Pereira, Joao
    Cardoso, Andre
    Braga, Isaac
    Freitas, Rui
    Correia, Tiago
    Cerqueira, Manuel
    Reis, Frederico Carmo
    Lobo, Francisco
    Silva, Vitor
    Magalhaes, Sanches
    Morais, Antonio
    Prisco, Rui
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (12) : 3163 - 3169
  • [50] Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Experience of a Single Institute in Taiwan
    Chou, Meng Han
    Kao, Chien Chang
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 436 - 436
12345